#United States #Austin #Alafair Biosciences #VersaWrap Hydrogel #VersaCoat Hydrogel

Alafair Biosciences Achieves Thrice the Honor

Alafair Biosciences, a prominent medical device firm from Austin, has proudly announced its place on the 2026 Inc. 5000 list for an impressive fourth consecutive year. This recognition marks a significant achievement for the company, known for innovating soft-tissue protection in orthopedic surgical procedures. The Inc. 5000 list highlights companies that have shown exceptional growth while contributing positively to the economy, creating jobs, and leading with forward-thinking practices.

Alafair’s latest accolade coincides with a significant product launch: the VersaCoat™ Flowable Hydrogel. This product enhances the existing portfolio of soft-tissue protection solutions by offering an easy-to-use, syringe-deliverable version of Alafair's advanced VersaCore™ Hydrogel Technology. The Flowable Hydrogel is designed for precise application in delicate areas, effectively creating a gliding interface that minimizes the risk of postoperative soft-tissue tethering.

The launch follows the success of the VersaWrap® Hydrogel Sheet, which has been widely adopted in more than 40,000 surgical implants across various medical specialties. With a strong foundation built on proven clinical use, the new VersaCoat Flowable Hydrogel enhances Alafair's mission to provide innovative solutions that empower surgeons and their patients.

John Joyoprayitno, the President and CEO of Alafair Biosciences, articulated the significance of this recognition. He stated, “Earning a spot on the Inc. 5000 for the fourth year in a row is powerful validation of the tireless work our team puts in every day.” He reinforced the company’s focus on ongoing growth through the expansion of its sales channels and product offerings, particularly emphasizing the recent launch of VersaCoat.

The latest Inc. 5000 listing features a remarkable cohort of companies that are not just growing but are also redefining what rapid growth looks like in today’s economy. The median revenue growth rate over the past three years among the companies listed was a remarkable 130%, underscoring the collective impact that these innovators are having on the U.S. economy, with over 627,208 new jobs created.

For a detailed view of the complete Inc. 5000 list and to explore honoree company profiles searchable by industry and location, visit the official Inc.com website.

About Alafair Biosciences

Alafair Biosciences focuses on pioneering biopolymer technology to revolutionize surgical soft-tissue protection. Its hallmark VersaCore™ Hydrogel Technology uniquely combines natural high-molecular-weight hyaluronic acid and alginate to create effective bioresorbable devices that facilitate natural healing processes. With products such as VersaWrap and the newest addition, VersaCoat, Alafair is dedicated to preventing soft-tissue tethering and supporting natural tissue mobility, thereby aiding surgeons in restoring optimal physical function for their patients.

Key Product Overview: VersaWrap and VersaCoat

1. VersaWrap® Hydrogel Sheet: This product offers a bioresorbable, hyaluronic acid, and alginate-based solution designed to provide a non-constricting interface for tendons and peripheral nerves, critical for ensuring mobility during the vital early healing stages. By eliminating the need for sutures, the VersaWrap creates uniform contact with tissue surfaces, supporting healing post-surgery.

2. VersaCoat™ Flowable Hydrogel: Specifically tailored for intricate anatomical areas, this hydrogel is engineered for precise application, forming a protective, tissue-attached layer that reduces tethering between tissue planes. It’s particularly useful in applications where traditional methods pose challenges, allowing for enhanced surgical efficacy and patient outcomes.

In summary, with its innovation-driven approach and continuous recognition in the Inc. 5000, Alafair Biosciences is poised for further contributions to orthopedic surgery, shaping the future of soft-tissue protection in surgical practices.